Kefavet® vet 500 mg, film-coated tablet
Kefavet® vet 500 mg, film-coated tablet
Authorised
- Cefalexin monohydrate
Product identification
Medicine name:
Kefavet® vet 500 mg, film-coated tablet
Kefavet Vet 500 mg Filmomhulde tablet
Kefavet Vet 500 mg Comprimé pelliculé
Kefavet Vet 500 mg Filmtablette
Active substance:
- Cefalexin monohydrate
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Cefalexin monohydrate526.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Film-coated tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01DB01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Available in:
-
Belgium
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Prodivet Pharmaceuticals
Marketing authorisation date:
Manufacturing sites for batch release:
- Orion Corporation
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V330933
Date of authorisation status change:
Reference member state:
-
Sweden
Procedure number:
- SE/V/0114/002
Concerned member states:
-
Belgium
-
Czechia
-
Denmark
-
Estonia
-
Hungary
-
Iceland
-
Latvia
-
Lithuania
-
Luxembourg
-
Netherlands
-
Poland
-
Romania
-
Slovakia
-
Slovenia
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
